Resource Library

biomarker discovery services partner

FFPE Multi-Omics for Precision Oncology Platforms

Extending molecular insights beyond DNA and RNA to realize new value in existing FFPE tissue biobanks.

FFPE Multi-Omics for Clinical Oncology

Unlocking functional biology, new biomarker insights, and responder profiles from archived trial samples.

FFPE Multi-Omics for Translational Oncology

Delivering quantitative, reproducible protein measures for rapid proof-of-mechanism & target engagement insights.

FFPE Multi-Omics for Discovery Oncology

Transforming archival tissue into a discovery-ready resource to move from target discovery to functional validation, in weeks.

Next-Generation FFPE Proteomics

Unlocking functional tumor biology from FFPE tissue – quantitatively, reproducibly, and at scale.

NULISAqpcr™ BD-pTau217 Assay

The only single-plex solution to offer absolute quantitation of brain-derived pTau217 in plasma.

NULISAseq™ Mouse Panel 120

To measure 120+ cytokines, chemokines, and immune- & neurology-related proteins from less than 25 μL of sample input.

Going Beyond the Genome in Rare Disease: The Value of a Multi-Omics Approach

Exploring why, to fully understand systemic pathology of rare diseases, we must look beyond genetic sequence alone.

Sapient Tumor Proteomics

Enabling deep characterization of cell surface and intracellular proteins in cancer cells.

Precision Protein Assays and Panels

For rapid turnaround of custom, quantitative protein assays and panels – no antibody or binding agent needed.

DynamiQ™ Insights Engine: Multi-Omics Database & Biorepository

With multi-omic & RWD from >62K samples, DynamiQ is among the most deeply phenotyped database for longitudinal study.

Mass Spectrometry-Based Proteomics & Protein Assays Fact Sheet

See how our methods enable deep coverage in diverse biofluids & tissue, and are scalable to your throughput needs.